Cite
Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience.
MLA
Zhu, Hongjian, et al. “Assessing Protocol Adherence in a Clinical Trial with Ordered Treatment Regimens: Quantifying the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial Experience.” Injury, vol. 47, no. 10, Oct. 2016, pp. 2131–37. EBSCOhost, https://doi.org/10.1016/j.injury.2016.07.028.
APA
Zhu, H., Fox, E. E., Baraniuk, S., Holcomb, J. B., Wade, C. E., Del Junco, D. J., Tilley, B. C., & PROPPR Study Group. (2016). Assessing protocol adherence in a clinical trial with ordered treatment regimens: Quantifying the pragmatic, randomized optimal platelet and plasma ratios (PROPPR) trial experience. Injury, 47(10), 2131–2137. https://doi.org/10.1016/j.injury.2016.07.028
Chicago
Zhu, Hongjian, Erin E. Fox, Sarah Baraniuk, John B. Holcomb, Charles E. Wade, Deborah J. Del Junco, Barbara C. Tilley, and PROPPR Study Group. 2016. “Assessing Protocol Adherence in a Clinical Trial with Ordered Treatment Regimens: Quantifying the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial Experience.” Injury 47 (10): 2131–37. doi:10.1016/j.injury.2016.07.028.